|
Market Closed -
Other stock markets
|
Pre-market 13:21:24 | |||
| 529.59 USD | +0.29% |
|
526.00 | -0.68% |
| 01:15pm | Equities Mostly Down Pre-Bell Amid Broad Chip Stock Sell-Off | MT |
| 12:34pm | RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $570 From $543, Maintains Outperform Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 547.44 | +3.37% | 27 | ||||||
| 1,224.68 | +2.05% | 28 | ||||||
| 257.95 | -0.53% | 22 | ||||||
| 258.32 | +1.4% | 28 | ||||||
| 359.22 | +8.26% | 18 | ||||||
| 217.23 | +15.36% | 22 | ||||||
| 153.86 | -0.79% | 21 | ||||||
| 316.49 | -1.43% | 24 | ||||||
| 354.76 | -3.19% | 29 | ||||||
| 158.48 | +22.28% | 27 | ||||||
| 29 | +22.27% | 27 | ||||||
| 63 | +11.11% | 24 | ||||||
| 21.14 | +6.62% | 19 | ||||||
| 96.49 | +29.5% | 23 | ||||||
| 10,006.67 | +32.7% | 15 | ||||||
| 52.89 | +3.34% | 18 | ||||||
| 81.21 | +43.06% | 15 | ||||||
| 6,106.87 | +10.69% | 15 | ||||||
| 4.142 | +15.55% | 17 | ||||||
| 434.72 | +38.87% | 25 | ||||||
| Average | 1,037.23 | +13.02% | 22 | ||||||
| Weighted average by Cap. | 702.64 | +6.27% | 24 |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
